Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson bought 269 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was bought at an average cost of GBX 56 ($0.73) per share, for a total transaction of £150.64 ($195.36).
Giles Wilson also recently made the following trade(s):
- On Tuesday, February 11th, Giles Wilson bought 207 shares of Dr. Martens stock. The stock was bought at an average cost of GBX 73 ($0.95) per share, for a total transaction of £151.11 ($195.97).
- On Monday, January 13th, Giles Wilson bought 222 shares of Dr. Martens stock. The stock was bought at an average cost of GBX 68 ($0.88) per share, for a total transaction of £150.96 ($195.77).
Dr. Martens Trading Up 1.3 %
Shares of DOCS opened at GBX 54.85 ($0.71) on Thursday. The company has a market capitalization of £532.46 million, a P/E ratio of 7.78, a P/E/G ratio of 6.40 and a beta of 0.11. Dr. Martens plc has a 1-year low of GBX 49.32 ($0.64) and a 1-year high of GBX 99.40 ($1.29). The firm’s 50 day simple moving average is GBX 68.58 and its 200 day simple moving average is GBX 64.81. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.
Dr. Martens Cuts Dividend
Dr. Martens Company Profile
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Read More
- Five stocks we like better than Dr. Martens
- Stock Average Calculator
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- 3 Best Fintech Stocks for a Portfolio Boost
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.